Maureen Riedl

University of Minnesota — United States

Medicine · Health Sciences

30h-index5.3kcitations64works2.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pain Mechanisms and Treatments(22), Neuropeptides and Animal Physiology(21), Receptor Mechanisms and Signaling(9), Lysosomal Storage Disorders Research(8), Virus-based gene therapy research(7)

Publications64 total

Chronic alcohol drinking delays recovery from capsaicin- and nerve injury-induced hypersensitivity in mice
Alcohol·2025· 2 cited
Chronic alcohol drinking delays recovery from capsaicin- and nerve injury-induced hypersensitivity in mice
2025Open Access
Transcriptomic Analysis of Kidney-Innervating Spinal and Vagal Sensory Neurons
Physiology·2025
Chronic Alcohol Consumption Leads to Prolonged Recovery from Tactile Hypersensitivity in Mouse Models of Persistent Pain
Journal of Pain·2025
Genetic risk factors underlying white matter hyperintensities and cortical atrophy
Nature Communications·2024· 12 citedOpen Access
AAV-mediated gene transfer to colon-innervating primary afferent neurons
Frontiers in Pain Research·2023· 1 citedOpen Access
Long-term reversal of chronic pain behavior in rodents through elevation of spinal agmatine
Molecular Therapy·2023· 13 citedOpen Access
Periglomerular afferent innervation of the mouse renal cortex
Frontiers in Neuroscience·2023· 22 citedOpen Access
Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
PLoS ONE·2022· 21 citedOpen Access
Biodistribution of Adeno-Associated Virus Serotype 5 Viral Vectors Following Intrathecal Injection
Molecular Pharmaceutics·2021· 8 citedOpen Access
Targeting the nociceptive somatosensory system with AAV9 and AAV2retro viral vectors
2021Open Access
Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I
Frontiers in Molecular Neuroscience·2021· 41 citedOpen Access
Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10
Molecular Genetics and Metabolism Reports·2020· 18 citedOpen Access
AAV-Mediated Gene Delivery to the Enteric Nervous System by Intracolonic Injection
Methods in molecular biology·2019· 10 citedOpen Access
Involvement of the VGF-derived peptide TLQP-62 in nerve injury–induced hypersensitivity and spinal neuroplasticity
Pain·2018· 14 cited
Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice
Pain·2017· 33 citedOpen Access
Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling
Glia·2017· 36 citedOpen Access
Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I
Human Gene Therapy·2017· 64 citedOpen Access
Relative effectiveness of different routes of AAV administration for gene therapy of mucopolysaccharidosis
Molecular Genetics and Metabolism·2017
25. Intranasal Gene Delivery of AAV Iduronidase: An Effective and Non-Invasive Approach for Treatmentof CNS Disease in a Murine Model of MPS Type I
Molecular Therapy·2016Open Access
page 1 of 4Next →

Frequent Co-authors

Lucy Vulchanova(35), Carolyn A. Fairbanks(16), Robert Elde(15), Kelley F. Kitto(15), R. Scott McIvor(10), Laura S. Stone(9), George L. Wilcox(9), Ulf Arvidsson(8), R. Elde(8), Christopher N. Honda(8), Lalitha R. Belur(7), Daniel J. Schuster(5), Kelly M. Podetz-Pedersen(5), Cristina D. Peterson(5), S.J. Shuster(4), Gary Buell(3), Annmarie Surprenant(3), R. Alan North(3), Jaclyn A. Dykstra(3), Horace H. Loh(3)